ALB and neoplasm: Shift from static analysis to dynamic survival management: While traditional methods predict patient survival rates based on TNM staging, AI introduces real-time dynamic indicators (such as tumor size, EBV DNA, and albumin) to enable dynamic risk stratification (31)